Display Settings:

Format

Send to:

Choose Destination
Int J Pediatr Endocrinol. 2012 Jul 30;2012(1):24. doi: 10.1186/1687-9856-2012-24.

Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes.

Author information

  • 1Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, 1775 Aurora Ct,, Mail Stop F527, Aurora, CO, 80045, USA. Franziska.Bishop@ucdenver.edu.

Abstract

Herein, we describe recruitment efforts for a trial of lipid-lowering medications in adolescents with type 1 diabetes, age 12-21 years. Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medication treatment guidelines for adolescents with type 1 diabetes.

PMID:
22846167
[PubMed]
PMCID:
PMC3476991
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk